Publications by authors named "Ko Fujimoto"

Claim this Profile
A
Antipsychotic Chlorpromazine Suppresses STAT5 Signaling, Overcomes Resistance Mediated by the Gatekeeper Mutation FLT3-ITD/F691L, and Synergizes with Quizartinib in FLT3-ITD-Positive Cells.
Aki Fujii-Hanamoto, Hirokazu Tanaka, Ko Fujimoto, Takahiro Haeno, Yoshiaki Miyake

Curr Issues Mol Biol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD34 and CD34 MM cells show different immune-checkpoint molecule expression profiles: high expression of CD112 and CD137 ligand on CD34 MM cells.
Ayano Fukui-Morimoto, Kentaro Serizawa, Ko Fujimoto, Aki Hanamoto, Yoshio Iwata

Int J Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).
Kensuke Usuki, Shigeki Ohtake, Sumihisa Honda, Mitsuhiro Matsuda, Atsushi Wakita, Ko Fujimoto

Int J Hematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).
Kensuke Usuki, Shigeki Ohtake, Sumihisa Honda, Mitsuhiro Matsuda, Atsushi Wakita, Ko Fujimoto

Int J Hematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma.
Takahiro Haeno, Shinya Rai, Yoshiaki Miyake, Maiko Inoue, Ko Fujimoto

J Clin Exp Hematop· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chlorpromazine cooperatively induces apoptosis with tyrosine kinase inhibitors in EGFR-mutated lung cancer cell lines and restores the sensitivity to gefitinib in T790M-harboring resistant cells.
Ryosuke Fujiwara, Yasuhiro Taniguchi, Shinya Rai, Yoshio Iwata, Aki Fujii, Ko Fujimoto

Biochem Biophys Res Commun· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab.
Shinya Rai, Hirokazu Tanaka, Ko Fujimoto, Takahiro Kumode, Hiroaki Inoue

Cancers (Basel)· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis